Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 747 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Motility Disorders Clear all

Conditions: Gastroesophageal Reflux
Interventions: VECAM 40/300, Esomeprazole 20 mg; Drug
Lead sponsor: Vecta Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: San Diego, California • Oklahoma City, Oklahoma

Conditions: Reflux
Interventions: pH study; Other
Lead sponsor: Kenneth Luberice; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Irritable Bowel Syndrome (IBS)
Interventions: Wireless Patch System; Diagnostic Test
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 18 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ocular Motility Disorders, Strabismus, Extraocular Muscle Dysfunction, Thyroid Eye Disease
Interventions: Glandy EOM (AI-based quantitative eye movement analysis software); Device
Lead sponsor: THYROSCOPE INC.; Industry
Eligibility: 22 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Jose, California

Conditions: Binocular Vision Disorder, Convergence Insufficiency, Headache, Computer Vision Syndrome
Interventions: Neurolens spectacle lens, Placebo spectacle lens; Device
Lead sponsor: Neurolens Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 10
States / cities: Phoenix, Arizona • Conyers, Georgia • Perry, Georgia + 7 more

Conditions: Motility Disorders
Interventions: Not listed
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Achalasia
Interventions: POEM; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Barrett's Esophagus, Intestinal Metaplasia, Gastroesophageal Reflux Disease (GERD)
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 80 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Gastroesophageal Reflux Disease (GERD), Heartburn, Indigestion
Interventions: Secretol, Nexium; Drug
Lead sponsor: Effexus Pharmaceutical; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Dysphagia, Dysplasia, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagitis, Gastroesophageal Reflux Disease, High Grade Dysplasia in Barrett Esophagus, Weight Loss
Interventions: Cytology Specimen Collection Procedure, Esophagogastroduodenoscopy, Laboratory Biomarker Analysis; Other · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Barrett Esophagus, Esophageal Adenocarcinoma
Interventions: Sponge Capsule; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 1,526 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 8
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Austin, Minnesota + 5 more

Conditions: Amblyopia, Anisometropic Ambyopia, Amblyopia, Suppression
Interventions: Anodal stimulation; Procedure
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Gastroesophageal Reflux, Esophageal Reflux, Gastroesophageal Reflux Disease, GERD
Interventions: Laparoscopic Hill Repair, Laparoscopic Nissen Repair; Procedure
Lead sponsor: Swedish Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Essential Tremor, Multiple System Atrophy, Corticobasal Degeneration, Supranuclear Palsy, Progressive, Parkinson Disease
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Gastroesophageal Reflux, Nervous System Diseases, Fundoplication, Enteral Nutrition
Interventions: Fundoplication, Gastrojejunal (GJ) feeding tube; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 6 Months to 18 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cough, Reflux
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: Rabeprazole sodium, Esomeprazole; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 85
States / cities: Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 73 more

Conditions: Amblyopia, Ocular Motility Disorders
Interventions: iCare, Amblyopia standard of Care, CI standard of Care; Device · Behavioral
Lead sponsor: Barron Associates, Inc.; Industry
Eligibility: 4 Years to 18 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Primary Ciliary Dyskinesia, Primary Immune Deficiency, Kartagener Syndrome
Interventions: Genetic Testing for PCD or PID, Unaffected Family Member Genetic Testing; Diagnostic Test · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 5 Years to 45 Years
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 6
States / cities: Palo Alto, California • Aurora, Colorado • Bethesda, Maryland + 3 more

Conditions: Gastroesophageal Reflux Disease, Diabetic Gastroparesis
Interventions: intervention letter; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gastroesophageal Reflux Disease
Interventions: E3710; Drug
Lead sponsor: Eisai Co., Ltd.; Industry
Eligibility: 20 Years to 40 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Glendale, California

Conditions: Primary Ciliary Dyskinesia
Interventions: Not listed
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 2 Years to 99 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Gastroesophageal Reflux Disease, Barrett's Esophagus, Esophagus Adenocarcinoma
Interventions: Primary Care Provider Survey, Gastroenterologist Survey, Patient Survey; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years
Enrollment: 725 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 7
States / cities: Aurora, Colorado • Philadelphia, Pennsylvania • Dallas, Texas

Conditions: Palsy Supranuclear, Supranuclear Palsy, Progressive
Interventions: Repetitive transcranial magnetic stimulation (rTMS); Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 40 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Search by objective public record fields.

Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux

Diet and Motility in IBS

Clinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)

Neurolens Headache Study

Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities

Peroral Endoscopic Myotomy (POEM) For The Treatment Of Achalasia: A Registry

Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

Esophageal Cytology With FISH in Detecting Esophageal Cancer

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Visual Cortex Stimulation in Patients With Amblyopia

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.

Comparative Anti-Reflux Procedures in Neurologically Impaired Children

Cough Monitoring Study

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Survey Study on Barrett's Esophagus Screening

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy